NUCHEV LIMITED — Capital/Financing Update 2026

May 14, 2026

ASX ANNOUNCEMENT | 15 May 2026

nuchev

15 May 2026

ASX Market Release

Nuchev Secures Working Capital Facility

Nuchev Limited (ASX: NUC) (Nuchev or the Company) advises that the Company has established a $4 million unsecured working capital facility (Facility) funded by a Substantial Shareholder of the Company, being H&S Global Holdings Pty Ltd ATF the H&S Investment Unit Trust (H&S).

Chief Executive Officer, Nathan Cheong, said: "Establishment of this Facility provides the Company with additional working capital flexibility to support the execution of its current growth plans across the group. We value and appreciate the ongoing support of H&S in providing this facility to the group."

The Facility has been established to assist the Company to fund its working capital requirements and to support ongoing business expansion and growth plans across the group in the short to medium term.

• The key commercial terms of the Facility are:
• Total facility limit of $4 million
• The Facility is unsecured
• The Facility is structured in two tranches of $2 million each
• The Facility matures on 31 March 2028
• Voluntary prepayments may be redrawn
• Interest is charged at the Bank Bill Swap Rate (BBSW) plus a margin of 10% per annum, payable quarterly in arrears
• A line fee of 1% per annum on the undrawn portion of the Facility is payable quarterly in arrears
• An establishment fee of 2% of the facility limit is payable
• Interest and fees may be capitalised at the Company's election

The Company advise that the Facility is a related party transaction, for the purposes of the ASX Listing Rules. The Board has determined that the Facility is on arm's length terms and, accordingly, shareholder approval is not required under ASX Listing Rule 10.1.

This announcement has been approved for release by the Board.

For further information please contact:

Nathan Cheong

Chief Executive Officer

nathan.cheong@nuchev.com.au

About Nuchev Limited

Nuchev is an Australian-based Nutritional and Wellness business. Nuchev's products include those branded under Oli6®, Bio Practica and Medicine Tree and a number of globally recognised European brands sold under exclusive licence in Australia and New Zealand by bWellness primarily to practitioners as prescription only products. Oli6® is sold in the key Australian Pharmacy and Grocery channels, online in China through the China Cross-Border e-Commerce (CBEC) and general trade retail channels, and has recently launched in Vietnam, where it is sold offline through Mother & Baby stores, other retail outlets and through online stores. Nuchev is also the exclusive agent for distribution of Brauer, Skin Physics and Rapid products in Australia. Nuchev is Inspiring healthier, happier futures for all and is committed to sourcing world class ingredients and industry leading, Australian manufacturing facilities that ensure the best possible products for our consumers.

nuchev

Nuchev Limited | ACN 163-225 090

Level 12, 636 St Kilda Road

Melbourne VIC 3004

www.nuchev.com.au